Protein residue characterization using AlphaFold
In this post of our AlphaFold Series, we present the new technology developed at Cyclica Inc. in...
From molecule to medicine
Neither AI nor HI are the silver bullet, but combined, they are
Recently, the Reproducibility Project: Cancer Biology published work that suggests that “more than...
AlphaFold2 coverage on multiple proteomes and impact on training MatchMaker
In the next post of our AlphaFold Series, we examined AlphaFold Human Proteome coverage, broken...
Deep Learning Across Label Confidence Distribution via Transfer Learning
When doing supervised machine learning, we would like to identify a relationship between some...
Deep learning as intelligent communication between neurons
Our natural networks of neurons work as decision-making systems with information processing units...
What differentiation really means (and what it does not)
It’s only a minor exaggeration to say that I get asked about differentiation on a daily basis....
Employee Spotlight - Steve Constable
When there's a technical problem that nobody can seem to solve, Steve arrives to save the day.
His...
A closer look at the coverage of the AlphaFold Human Proteome
In this post of our AlphaFold Series, we look at the gaps in proteome coverage addressed by...
AlphaFold 2: What No One Is Talking About
In this next installment of our AlphaFold Series, we look at the potential drawbacks and...
Building Good Partnerships
At my job, I was frequently asked by external parties what I meant by saying, “Cyclica is a drug...